Condition

GC/GEJC clinical trials and research

As of November 12, 2026, Find a Trial lists 3 GC/GEJC clinical trials that are recruiting, in China. By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest GC/GEJC clinical trials

StudyPhaseWhereStatusRegistered
A combination therapy for advanced second-line gastric cancer using apatinib with albumin-bound paclitaxel, with or without adebrelimab Phase 2 Zhengzhou, Henan Recruiting Aug 18, 2026
Disitamab vedotin plus SOX versus SOX alone as adjuvant treatment for HER2-moderate/high stage III gastric cancer after surgery Phase 2 Nanjing, Jiangsu Recruiting Mar 16, 2026
Combination of adebrelimab and XELOX for treating advanced gastric cancer before surgery Phase 2 Tianjin, Tianjin Municipality Recruiting Jul 17, 2024

All recruiting trials (3)

Related topics

AdebrelimabAdebrelimab (SHR-1316)ApatinibDisitamab

Quick answers

How many GC/GEJC clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.